PureHealth completes 60% acquisition of Greek-Cypriot HHG: Abu Dhabi healthcare group PureHealth finalized its acquisition of a 60% equity stake in Greek-Cypriot hospital group Hellenic Healthcare Group (HHG), after securing regulatory clearance under the EU Foreign Subsidies Regulation, according to an ADX disclosure (pdf). The transaction value was not disclosed.

REMEMBER- PureHealth signed a definitive agreement in January to acquire the stake in the largest hospital operator in Greece and Cyprus — then valued at USD 2.3 bn — from CVC Capital Partners VI and HHG founder Dimitrios Spyridis. Following the transaction, CVC retains a 35% share and Spyridis holds 5%, leaving PureHealth with a controlling interest in HHG through a wholly owned subsidiary.

Financial impact soon to show: HHG’s financials have been consolidated into PureHealth’s accounts starting 1 October 2025. The takeover falls within PureHealth’s goal to diversify revenues streams and have over half of its revenues coming from outside the GCC, Group CEO at PureHealth Shaista Asif previously said.

The move extends PureHealth’s global healthcare M&A spree: The acquisition adds to the group’s USD 1.2 bn purchase of the UK’s Circle Health Group, and its acquisition of a USD 1.8 bn stake in US-based Ardent Health Services. Closer to home, PureHealth holds a 25% stake in Sheikh Shakhbout Medical City for USD 150 mn and was previously linked to a potential takeover of NMC Healthcare in the UAE, which it reportedly dropped over valuation differences.

IN OTHER M&A NEWS-

IHC finalizes exit from Reach Group: Abu Dhabi’s International Holding Company (IHC) has divested its entire 55% stake in Emirati recruitment company Reach Group, according to an ADX disclosure (pdf). IHC acquired its stake in Reach Group back in 2023 for AED 315 mn as it looked to scale local and international investments, and increase its capital share in the employment sector.

One out, one in: IHC recently agreed to acquire a 41.2% stake in Mumbai-listed, mortgage-focused Sammaan Capital for USD 1 bn, pending regulatory approval. The firm is looking to invest heavily in India, earmarking USD 110 bn in investments for the country over the next five years.